News in Numbers

$20bn

Sanofi has committed to invest ‘at least’ $20bn to US manufacturing through 2030. 

$32.1bn

The HIV market is expected to reach $32.1bn by 2033 in the seven major markets.

$1.34bn

BioNTech has announced plans to invest $1.34bn in UK R&D. 

27%

As per provisional data from the CDC's National Vital Statistics System there was a decrease of around 27% of drug overdose deaths in 2024 compared to 2023 

41%

A new study found that GLP1-RAs had a direct effect on reducing obesity-related cancer beyond weight loss, with a 41% lower relative risk compared to bariatric surgery.

Go to article: Home | Are regulators keeping pace with AI adoption in clinical trials?Go to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: Cartherics Company InsightGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Datwyler Company InsightGo to article: DatwylerGo to article: NiproGo to article: In DepthGo to article: Are regulators keeping pace with AI adoption in clinical trials?Go to article: Power of collaboration more pertinent than ever says pharma expertsGo to article: Newborn screening strategy needs modernising as HHS disbands advisory committeeGo to article: Pharma’s AI prospects get nudged into the future with EU’s AI actGo to article: ATS 2025: Anti–IL-5 therapy cuts exacerbations in coexisting COPD and asthma patientsGo to article: ATS 2025: Real-world data supports Trikafta as gold standard in long-term CF careGo to article: B Medical Systems Company InsightGo to article: Endress+HauserGo to article: SCHOTT Pharma Company InsightGo to article: ListingsGo to article: EventsGo to article: Excellence AwardsGo to article: Buyer's GuidesGo to article: Next issue